Literature DB >> 8282618

Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits.

J P Wiener-Kronish1, T Sakuma, I Kudoh, J F Pittet, D Frank, L Dobbs, M L Vasil, M A Matthay.   

Abstract

We developed an experimental model of acute Pseudomonas aeruginosa pneumonia in anesthetized ventilated rabbits to determine whether bacterial-induced injury to the alveolar epithelium would occur and the effect of the injury on the pleural space. Dose-response studies established that 10(9) colony-forming units of P. aeruginosa (wild-type strain, PAO-1) were required to injure the epithelial barrier and to cause pleural empyema with exudative pleural effusions that contained both the instilled alveolar protein tracer and P. aeruginosa. We explored the mechanisms of P. aeruginosa-induced lung and pleural injury by using three isogenic bacterial strains to compare several extracellular virulence products. PAO-S21, which carries an insertion mutation in a regulatory gene that prevents the production of exoenzyme S, resulted in no lung or pleural injury. PAO-R1, which carries a deletion in a regulatory gene that controls the production of elastase and alkaline protease, caused the same degree of lung and pleural injury as PAO-1 did. Instillation of PLC-SRN, which has both structural genes encoding phospholipase C activity deleted, resulted in a moderate reduction in alveolar epithelial injury. Although other products may be involved, exoenzyme S and phospholipase C are important in mediating injury to the alveolar epithelial barrier in acute P. aeruginosa pneumonia in rabbits.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282618     DOI: 10.1152/jappl.1993.75.4.1661

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  42 in total

1.  Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity.

Authors:  L S Terada; K A Johansen; S Nowbar; A I Vasil; M L Vasil
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells.

Authors:  Anders Frisk; Jill R Schurr; Guoshun Wang; Donna C Bertucci; Luis Marrero; Sung Hei Hwang; Daniel J Hassett; Michael J Schurr
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 4.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

5.  Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy.

Authors:  T Sakuma; K Takahashi; N Ohya; K Usuda; M Handa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 6.  Alveolar epithelial ion and fluid transport: recent progress.

Authors:  Hans G Folkesson; Michael A Matthay
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-02       Impact factor: 6.914

7.  Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Authors:  N G Barclay; J C Spurrell; T F Bruno; D G Storey; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

8.  Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.

Authors:  Teiji Sawa; Emi Ito; Vinh Huu Nguyen; Matthew Haight
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Characterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolase.

Authors:  Jamie A Meadows; Matthew J Wargo
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

Review 10.  Pneumonia and empyema: causal, casual or unknown.

Authors:  Lindsay McCauley; Nathan Dean
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.